SG11201605186QA - Beta-hairpin peptidomimetics as selective elastase inhibitors - Google Patents
Beta-hairpin peptidomimetics as selective elastase inhibitorsInfo
- Publication number
- SG11201605186QA SG11201605186QA SG11201605186QA SG11201605186QA SG11201605186QA SG 11201605186Q A SG11201605186Q A SG 11201605186QA SG 11201605186Q A SG11201605186Q A SG 11201605186QA SG 11201605186Q A SG11201605186Q A SG 11201605186QA SG 11201605186Q A SG11201605186Q A SG 11201605186QA
- Authority
- SG
- Singapore
- Prior art keywords
- beta
- elastase inhibitors
- hairpin peptidomimetics
- selective
- selective elastase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/10—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2013/078072 WO2015096872A1 (en) | 2013-12-27 | 2013-12-27 | Beta-hairpin peptidomimetics as selective elastase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201605186QA true SG11201605186QA (en) | 2016-07-28 |
Family
ID=49955308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201605186QA SG11201605186QA (en) | 2013-12-27 | 2013-12-27 | Beta-hairpin peptidomimetics as selective elastase inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10723765B2 (en) |
| EP (1) | EP3087087B1 (en) |
| JP (1) | JP6499182B2 (en) |
| KR (1) | KR102214693B1 (en) |
| CN (1) | CN105873939B (en) |
| AU (1) | AU2013409231B2 (en) |
| BR (1) | BR112016015018B1 (en) |
| CA (1) | CA2933656C (en) |
| EA (1) | EA034910B1 (en) |
| ES (1) | ES2957258T3 (en) |
| IL (1) | IL246108B (en) |
| MX (1) | MX2016008468A (en) |
| NZ (1) | NZ722030A (en) |
| SG (1) | SG11201605186QA (en) |
| WO (1) | WO2015096872A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007008150D1 (en) | 2007-02-28 | 2010-09-09 | Polyphor Ltd | TEMPLAT-FIXED PEPTIDOMIMETIKA |
| CN106029689B (en) * | 2013-12-27 | 2021-09-28 | 波利弗尔股份公司 | Beta-hairpin peptidomimetics as selective elastase inhibitors |
| RS63622B1 (en) * | 2016-05-31 | 2022-10-31 | Spexis Ag | Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof |
| JP2023500182A (en) | 2019-09-17 | 2023-01-05 | メレオ バイオファーマ ４ リミテッド | Alberestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome, and graft-versus-host disease |
| EP4252850A3 (en) | 2020-04-16 | 2023-11-15 | Mereo Biopharma 4 Limited | Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency |
| WO2023067103A1 (en) | 2021-10-20 | 2023-04-27 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| GB9825854D0 (en) | 1998-11-25 | 1999-01-20 | Univ Bristol | Peptide |
| CN1386759A (en) * | 2001-05-17 | 2002-12-25 | 上海博德基因开发有限公司 | Polypeptide-elastatinal-43.12 and polynucleotide for coding it |
| CN101157924A (en) * | 2001-12-11 | 2008-04-09 | 人体基因组科学有限公司 | Neutrophil leukocyte gene alpha |
| PL1856140T3 (en) * | 2005-02-17 | 2014-06-30 | Polyphor Ltd | Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity |
| CN102499925B (en) * | 2011-10-21 | 2015-11-11 | 上海中医药大学 | A kind of neutrophil elastase inhibitor |
| CN106029689B (en) * | 2013-12-27 | 2021-09-28 | 波利弗尔股份公司 | Beta-hairpin peptidomimetics as selective elastase inhibitors |
-
2013
- 2013-12-27 CN CN201380081887.5A patent/CN105873939B/en active Active
- 2013-12-27 JP JP2016543030A patent/JP6499182B2/en active Active
- 2013-12-27 ES ES13820780T patent/ES2957258T3/en active Active
- 2013-12-27 SG SG11201605186QA patent/SG11201605186QA/en unknown
- 2013-12-27 US US15/107,980 patent/US10723765B2/en active Active
- 2013-12-27 NZ NZ722030A patent/NZ722030A/en unknown
- 2013-12-27 WO PCT/EP2013/078072 patent/WO2015096872A1/en active Application Filing
- 2013-12-27 EA EA201691328A patent/EA034910B1/en unknown
- 2013-12-27 KR KR1020167020451A patent/KR102214693B1/en active IP Right Grant
- 2013-12-27 MX MX2016008468A patent/MX2016008468A/en unknown
- 2013-12-27 AU AU2013409231A patent/AU2013409231B2/en active Active
- 2013-12-27 EP EP13820780.8A patent/EP3087087B1/en active Active
- 2013-12-27 BR BR112016015018-0A patent/BR112016015018B1/en active IP Right Grant
- 2013-12-27 CA CA2933656A patent/CA2933656C/en active Active
-
2016
- 2016-06-08 IL IL246108A patent/IL246108B/en active IP Right Grant
-
2020
- 2020-06-18 US US16/904,920 patent/US20200317735A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016015018A2 (en) | 2017-08-08 |
| MX2016008468A (en) | 2016-09-26 |
| NZ722030A (en) | 2019-06-28 |
| AU2013409231B2 (en) | 2019-08-01 |
| CA2933656A1 (en) | 2015-07-02 |
| EP3087087B1 (en) | 2021-07-21 |
| IL246108B (en) | 2021-06-30 |
| US20160318976A1 (en) | 2016-11-03 |
| AU2013409231A1 (en) | 2016-07-21 |
| CA2933656C (en) | 2021-04-20 |
| WO2015096872A1 (en) | 2015-07-02 |
| CN105873939B (en) | 2021-08-27 |
| JP2017504619A (en) | 2017-02-09 |
| IL246108A0 (en) | 2016-07-31 |
| EA034910B1 (en) | 2020-04-06 |
| EP3087087A1 (en) | 2016-11-02 |
| ES2957258T3 (en) | 2024-01-16 |
| JP6499182B2 (en) | 2019-04-10 |
| KR20160102068A (en) | 2016-08-26 |
| CN105873939A (en) | 2016-08-17 |
| BR112016015018B1 (en) | 2022-10-04 |
| KR102214693B1 (en) | 2021-02-10 |
| US10723765B2 (en) | 2020-07-28 |
| EA201691328A1 (en) | 2016-10-31 |
| US20200317735A1 (en) | 2020-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1256999A1 (en) | Syk inhibitors | |
| IL235946A0 (en) | Beta-hairpin peptidomimetics | |
| SG11201600373YA (en) | Syk inhibitors | |
| HK1216531A1 (en) | Novel inhibitors | |
| ZA201604821B (en) | Beta-hairpin peptidomimetics as selective elastase inhibitors | |
| IL246108A0 (en) | Beta-hairpin peptidomimetics as selective elastase inhibitors | |
| HK1225399A1 (en) | Beta-hairpin peptidomimetics | |
| GB201317609D0 (en) | Inhibitor compounds | |
| SG11201509650YA (en) | Slc2a transporter inhibitors | |
| ZA201507428B (en) | Beta-hairpin peptidomimetics | |
| HK1217702A1 (en) | Hdac inhibitors hdac | |
| EP2970107A4 (en) | Photoswitchable hdac inhibitors | |
| HK1211626A1 (en) | Predicting response to egfr inhibitors egfr | |
| HK1225398A1 (en) | Beta-hairpin peptidomimetics as selective elastase inhibitors | |
| GB201321328D0 (en) | Inhibitor compounds | |
| GB201305503D0 (en) | Inhibitor |